These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
698 related articles for article (PubMed ID: 27490779)
21. Dihydromyricetin ameliorates oleic acid-induced lipid accumulation in L02 and HepG2 cells by inhibiting lipogenesis and oxidative stress. Xie C; Chen Z; Zhang C; Xu X; Jin J; Zhan W; Han T; Wang J Life Sci; 2016 Jul; 157():131-139. PubMed ID: 27265384 [TBL] [Abstract][Full Text] [Related]
22. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530 [TBL] [Abstract][Full Text] [Related]
23. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway. Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077 [TBL] [Abstract][Full Text] [Related]
24. Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635 [No Abstract] [Full Text] [Related]
25. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952 [TBL] [Abstract][Full Text] [Related]
26. Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells. Zeng L; Tang W; Yin J; Feng L; Li Y; Yao X; Zhou B Cell Physiol Biochem; 2016; 40(3-4):453-464. PubMed ID: 27889747 [TBL] [Abstract][Full Text] [Related]
27. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation. Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764 [TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685 [TBL] [Abstract][Full Text] [Related]
29. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways. Chen KY; Lin JA; Yao HY; Hsu AC; Tai YT; Chen JT; Hsieh MC; Shen TL; Hsu RY; Wu HT; Wang GH; Ho BY; Chen YP Nutr Res; 2018 Apr; 52():87-97. PubMed ID: 29525610 [TBL] [Abstract][Full Text] [Related]
30. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945 [TBL] [Abstract][Full Text] [Related]
31. Effect of silibinin on CFLAR-JNK pathway in oleic acid-treated HepG2 cells. Liu Y; Yu Q; Chen Y Biomed Pharmacother; 2018 Dec; 108():716-723. PubMed ID: 30248539 [TBL] [Abstract][Full Text] [Related]
32. Mulberry extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance. Ou TT; Hsu MJ; Chan KC; Huang CN; Ho HH; Wang CJ J Sci Food Agric; 2011 Dec; 91(15):2740-8. PubMed ID: 22002411 [TBL] [Abstract][Full Text] [Related]
33. Berbamine induced AMPK activation regulates mTOR/SREBP-1c axis and Nrf2/ARE pathway to allay lipid accumulation and oxidative stress in steatotic HepG2 cells. Sharma A; Anand SK; Singh N; Dwivedi UN; Kakkar P Eur J Pharmacol; 2020 Sep; 882():173244. PubMed ID: 32526241 [TBL] [Abstract][Full Text] [Related]
34. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity. Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220 [TBL] [Abstract][Full Text] [Related]
35. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells. Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265 [TBL] [Abstract][Full Text] [Related]
36. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase. Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686 [TBL] [Abstract][Full Text] [Related]
37. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation. Choi du G; Kim EK; Yang JW; Song JS; Kim YM Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190 [TBL] [Abstract][Full Text] [Related]
38. Melatonin Modulates lipid Metabolism in HepG2 Cells Cultured in High Concentrations of Oleic Acid: AMPK Pathway Activation may Play an Important Role. Mi Y; Tan D; He Y; Zhou X; Zhou Q; Ji S Cell Biochem Biophys; 2018 Dec; 76(4):463-470. PubMed ID: 30324559 [TBL] [Abstract][Full Text] [Related]
39. AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development. Boudaba N; Marion A; Huet C; Pierre R; Viollet B; Foretz M EBioMedicine; 2018 Feb; 28():194-209. PubMed ID: 29343420 [TBL] [Abstract][Full Text] [Related]
40. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway. Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]